New liver support method aims to boost recovery in severe liver failure
NCT ID NCT07593638
First seen May 20, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tests whether a combination of blood filtering (hemoadsorption) and half-dose plasma exchange can help adults with acute-on-chronic liver failure (ACLF) recover or stay stable until a liver transplant. About 240 participants will receive either this liver support protocol or standard care. The main goal is to see if the treatment reduces death or the need for transplant within 28 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unidade Hospitalar de Bragança
Bragança, Braganza District, 5301-852, Portugal
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.